Eudaimonia Asset Management »

Adma Biologics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.1M 622k 6.60
2023-09-30 $3.5M 967k 3.58
2023-06-30 $3.3M 884k 3.69
2023-03-31 $3.3M 345k 9.61
2022-12-31 $6.8M 1.7M 3.88
2022-09-30 $3.5M 1.4M 2.43
2022-06-30 $2.5M 1.2M 1.98

More positions owned by Eudaimonia Asset Management

Super Micro Computer Common Stock (SMCI)
FTAI Aviation Common Stock (FIP)
Viking Therapeutics Common Stock (VKTX)
Applied Industrial Technologies Common Stock (AIT)
NEXTracker Common Stock (NXT)
Comfort Systems USA Common Stock (FIX)
Aaon Common Stock (AAON)
Leonardo SpA Common Stock (DRS)
Sweetgreen Common Stock (SG)
Dycom Industries Common Stock (DY)
Ryman Hospitality Properties Common Stock (RHP)
Installed Building Products Common Stock (IBP)
Crinetics Pharmaceuticals Common Stock (CRNX)
RxSight Common Stock (RXST)
Q2 Holdings Common Stock (QTWO)

View all positions for Eudaimonia Asset Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
Nuveen Asset Management
American Century Companies
Perceptive Advisors
AWM Investment Company
D. E. Shaw & Co
Geode Capital Management
Two Sigma Investments
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Advisers
Ophir Asset Management Pty
Assenagon Asset Management
Deutsche Bank Aktiengesellschaft

View all funds holding Adma Biologics